Scarica l'app Stockscreener
8.75
12.15%
-1.21
Candel Therapeutics Inc Borsa (CADL) Ultime notizie
Research Analysts Set Expectations for CADL FY2024 Earnings - Defense World
FY2024 Earnings Forecast for CADL Issued By HC Wainwright - MarketBeat
Candel Therapeutics Shares Leap on Chairman Purchase - MarketWatch
Candel Therapeutics rides high on promising Phase 3 data, funding boost - Proactive Investors UK
Candel Therapeutics Inc call volume above normal and directionally bullish - TipRanks
Insider Buying: Candel Therapeutics, Inc. (NASDAQ:CADL) Director Purchases 1,250,000 Shares of Stock - MarketBeat
Candel Therapeutics stock upgraded as CAN-2409 delivers in prostate cancer trial - Investing.com
Candel Therapeutics aims to transform cancer outcomes - Proactive financial news
HC Wainwright Reiterates Buy Rating for Candel Therapeutics (NASDAQ:CADL) - MarketBeat
Candel Therapeutics Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares - The Manila Times
Candel Therapeutics raises $92M in public offering following prostate cancer trial success - Proactive financial news
StockWatch: Q32 Shares Crater 85% as Investors, Analysts Sour on Trial Results - Genetic Engineering & Biotechnology News
Candel Therapeutics announces $80 million proposed public offering - MSN
Candel Therapeutics (NASDAQ:CADL) Stock Quotes, Forecast and News Summary - Benzinga
SEC Form 424B5 filed by Candel Therapeutics Inc. - Quantisnow
Candel’s Phase III Prostate Cancer Win Comes In the Nick Of Time - Citeline News & Insights
What's Going On With Candel Therapeutics Shares Friday? - Benzinga
Candel Therapeutics, 8x8 And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Candel Therapeutics unveils $80M public offering - Proactive Investors Australia
Candel Therapeutics stock drops after pricing public offering By Investing.com - Investing.com Canada
Candel Therapeutics stock drops after pricing public offering - Investing.com
CADL Stock Soars as Phase III Prostate Cancer Study Meets Primary Goal - MSN
Candel Therapeutics Shares Fall Premarket After Public Offering - MarketWatch
Candel Therapeutics Announces Positive Phase 3 Trial Results for CAN-2409 in Prostate Cancer - Defense World
Candel Therapeutics Target of Unusually Large Options Trading (NASDAQ:CADL) - Defense World
Candel Therapeutics Prices of Public Offering - citybiz
Candel Therapeutics Launches $80M Public Offering to Advance Prostate Cancer Treatment Pipeline - StockTitan
Candel Therapeutics Announces Pricing of Public Offering - The Manila Times
After-hours movers: Broadcom, Costco, EVgo, Candel Therapeutics By Investing.com - Investing.com Canada
Candel Therapeutics slides after launching $80 mln stock offering - XM
Candel Therapeutics Announces $80 Million Proposed Public Offering - The Manila Times
After-hours movers: Broadcom, Costco, EVgo, Candel Therapeutics - Investing.com
Candel Therapeutics Shares Are Up Today: What's Going On? - Benzinga
Candel Therapeutics stock soars to 52-week high of $14.47 By Investing.com - Investing.com Nigeria
Gamestop, Adobe, Meta, Candel Therapeutics, And Tesla: Why These 5 Stocks Are On Investors' Radars Today - Benzinga
Candel Therapeutics Stock More Than Doubles After Strong Prostate Cancer Trial Results: Retail Goes Wild - MSN
Candel leads biotech gainers amid wave of data readouts - BioCentury
Candel stock rockets on Phase 3 results for CAN-2409 (update) - MSN
Candel Skyrockets 68% On A Potential First-In-20-Years Cancer Drug - Yahoo! Voices
Biotech Rockets 68% On A Potential First-In-Decades Drug - Investor's Business Daily
Candel Therapeutics Prostate Cancer Therapy Shows Promise - Yahoo Finance
Crude Oil Jumps 2%; Macy's Lowers Earnings Forecast - Benzinga
Candel stock rockets 130% on Phase 3 results for CAN-2409 - MSN
Candel Therapeutics: Surprising Win Puts Potential Drug Approval In Sight (CADL) - Seeking Alpha
Wick-ed good phase III prostate cancer data light up Candel - BioWorld Online
Candel Therapeutics Stock Surges Over 100%Here's Why - AOL
U.S. STOCKS Candel Therapeutics, Broadcom, Reddit - XM
Candel's cancer therapy meets late-stage trial goal, shares soar - Reuters
Biotech Stock Hits 3-Year Highs on Trial Results - Schaeffers Research
Nasdaq Surges Over 1%; US Inflation Rises In-Line With Expectations - Benzinga
Candel Therapeutics stock up 172% after Phase III prostate cancer success - Yahoo Finance
Candel Therapeutics shares surge on positive Phase 3 results for CAN-2409 in localized prostate cancer - Proactive Investors USA
Candel Therapeutics stock soars to 52-week high of $14.47 - Investing.com
Candel Skyrockets By Triple Digits On A Potential First-In-20-Years Cancer Drug - Inkl
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):